Unilateral Serous Macular Detachment Accompanying Cystoid Macular Edema Temporally Associated with COVID-19 Vaccination
DOI:
https://doi.org/10.62856/djcro.v7.48Keywords:
COVID-19, Cystoid macular edema, Serous macular detachment, Sinopharm, VaccinationAbstract
A 67-year-old male presented with progressive vision loss in his left eye seven days after receiving the second dose of the COVID-19 vaccine (BBIBP-CorV, Sinopharm, Beijing, China). Fundus examination and spectral-domain optical coherence tomography angiography (SD-OCTA; Optovue, Fremont, CA) showed serous macular detachment with cystoid macular edema (CME) in the left eye. The patient’s best-corrected visual acuity improved dramatically from counting fingers at 3 m to 20/32, and macular detachment and CME resolved significantly within 10 days, without any treatment. This observation suggests a potential link between transient serous macular detachment accompanying CME and the Sinopharm COVID-19 vaccination. Nevertheless, it is important to emphasize that vaccination against COVID-19 is highly recommended.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The Contributor assigns to Duke, during the full term of copyright and any extensions or renewals, all copyright in and to the Manuscript, and all rights therein, including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the Manuscript in whole or in part in electronic editions of the DJCRO and in derivative works throughout the world, in all languages and in all media of expression now known or later developed, and to license or permit others to do so. "Manuscript" means the article submitted by the Contributor for publication in the DJCRO (including any embedded rich media) and all subsequent versions. The definition of Manuscript does not extend to any supporting information submitted with or referred to in the Manuscript ("Supporting Information"). To the extent that any Supporting Information is submitted to the DJCRO, Duke is granted a perpetual, non-exclusive license to publish, republish, transmit, sell, distribute and otherwise use this Supporting Information in whole or in part in electronic and print editions of the DJCRO and in derivative works throughout the world, in all languages and in all media of expression now known or later developed, and to license or permit others to do so. If the Manuscript was shared as a preprint, the Contributor grants to Duke exclusivity as to any rights retained by the Contributor in the preprint.
Reproduction, posting, transmission or other distribution or use of the final Manuscript in whole or in part in any medium by the Contributor as permitted by this Agreement requires a citation to the DJCRO suitable in form and content as follows: (Contributor(s), Title of Manuscript, Journal Title, Journal Volume, Copyright© [year], Digital Object Identifier [DOI] link to final Manuscript). Links to the final article on the DJCRO website are also encouraged where appropriate.
